Comparing Cost-Effectiveness Of Emerging Drugs In Advanced Cancer Without Hazard Ratios For Progression
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2551
https://www.valueinhealthjournal.com/article/S1098-3015(15)04627-6/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1958
First Page :
A688
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04627-6&doi=10.1016/j.jval.2015.09.2551